Indacaterol is a β2-agonist with a rapid onset of action and a bronchodilating effect that lasts for 24 h.
Cazzola, M., Calzetta, L., Page, C., Matera, M. (2014). Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 10(1), 129-137 [10.1517/17425255.2014.865723].
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation
CAZZOLA, MARIO;
2014-01-01
Abstract
Indacaterol is a β2-agonist with a rapid onset of action and a bronchodilating effect that lasts for 24 h.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
